author-photo

Cassandra M. Hennies

Cincinnati Children's Hospital Medical Center

11

Papers

246

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Type I IFN Drives Experimental Systemic Lupus Erythematosus by Distinct Mechanisms in CD4 T Cells and B Cells.

2020
Show All
- Source
- Cite
- Save
Citations (9)
Author Correction: Ablation of CD8α+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (7)
Author Correction: Ablation of CD8α+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice (Scientific Reports, (2015), 5, 1, (15414), 10.1038/srep15414)

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.

2015 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (69)
Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.

2015 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (17)
メロサイトの樹状細胞およびCD8DCの選択的増殖はin vivoにおいてFms様チロシンキナーゼ3-リガンド投与の抗腫瘍作用をもたらす | 文献情報 | J-GLOBAL 科学技術総合リンクセンター

2011 Clinical and Experimental Immunology
Show All
- Source
- Cite
- Save
Citations (0)
メロサイトの樹状細胞およびCD8DCの選択的増殖はin vivoにおいてFms様チロシンキナーゼ3-リガンド投与の抗腫瘍作用をもたらす

2011 Clinical and Experimental Immunology
Show All
- Source
- Cite
- Save
Citations (0)